Neuro-oncological ventral antigen 1 (Nova1) was first identified as a neuron-specific RNA binding protein in paraneoplastic opsoclonus-myoclonus ataxia (POMA), which is associated with breast cancer, fallopian cancer and small cell lung cancer [4], [5]. This evidence concerns the gene NOVA1 and small cell lung carcinoma.